Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation

被引:10
|
作者
Haciislamoglu, Emel [1 ]
Gungor, Gorkem [2 ]
Aydin, Gokhan [2 ]
Canyilmaz, Emine [1 ]
Guler, Ozan Cem [3 ]
Zengin, Ahmet Yasar [4 ]
Yenice, Kamil Mehmet [5 ]
机构
[1] Karadeniz Tech Univ, Fac Med, Dept Radiat Oncol, Trabzon, Turkey
[2] Acibadem Univ, Dept Radiat Oncol, Istanbul, Turkey
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana, Turkey
[4] Kanuni Res & Educ Hosp, Dept Radiat Oncol, Trabzon, Turkey
[5] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
来源
关键词
flattening filter free (FFF); prostate cancer; radiation-induced secondary cancer; radiotherapy (RT); volumetric modulated arc therapy (VMAT); INTENSITY-MODULATED RADIOTHERAPY; ATOMIC-BOMB SURVIVORS; RADIATION-INDUCED CANCER; OF-FIELD PHOTON; CALCULATED RISK; SOLID CANCER; ARC THERAPY; FLATTENING FILTER; 2ND CANCERS; EXPOSURE;
D O I
10.1002/acm2.12972
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We aimed to estimate the risk of secondary cancer after radiotherapy (RT) in high-risk prostate cancer (HRPC) patients with pelvic irradiation. Computed tomography data of five biopsy-proven HRPC patients were selected for this study. Two different planning target volumes (PTV(1)and PTV2) were contoured for each patient. The PTV(1)included the prostate, seminal vesicles, and pelvic lymphatics, while the PTV(2)included only the prostate and seminal vesicles. The prescribed dose was 54 Gy for the PTV(1)with a sequential boost (24 Gy for the PTV2). Intensity-modulated RT (IMRT) and volumetric modulated arc therapy (VMAT) techniques were used to generate treatment plans with 6 and 10 MV photon energies with the flattening filter (FF) or flattening filter-free (FFF) irradiation mode. The excess absolute risks (EARs) were calculated and compared for the bladder, rectum, pelvic bone, and soft tissue based on the linear-exponential, plateau, full mechanistic, and specific mechanistic sarcoma dose-response model. According to the models, all treatment plans resulted in similar risks of secondary bladder or rectal cancer and pelvic bone or soft tissue sarcoma except for the estimated risk of the bladder according to the full mechanistic model using IMRT((6MV;FF))technique compared with VMAT techniques with FFF options. The overall estimation of EAR indicated that the radiation-induced cancer risk due to RT in HRPC was lower for bladder than the rectum. EAR values ranged from 1.47 to 5.82 for bladder and 6.36 to 7.94 for rectum, depending on the dose-response models used. The absolute risks of the secondary pelvic bone and soft tissue sarcoma were small for the plans examined. We theoretically predicted the radiation-induced secondary cancer risk in HRPC patients with pelvic irradiation. Nevertheless, prospective clinical trials, with larger patient cohorts with a long-term follow-up, are needed to validate these model predictions.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 50 条
  • [41] Controversies in the therapy of high-risk prostate cancer. Radiotherapy
    Boehmer, D.
    ONKOLOGE, 2015, 21 (09): : 805 - +
  • [42] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    Thoms, John
    Goda, Jayant S.
    Zlotta, Alexendre R.
    Fleshner, Neil E.
    van der Kwast, Theodorus H.
    Supiot, St Phane
    Warde, Padraig
    Bristow, Robert G.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (02) : 107 - 113
  • [43] Radical Radiotherapy for High-Risk Prostate Cancer in Older Men
    Payne, Heather A.
    Hughes, Simon
    ONCOLOGIST, 2012, 17 : 9 - 15
  • [44] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    John Thoms
    Jayant S. Goda
    Alexender R. Zlotta
    Neil E. Fleshner
    Theodorus H. van der Kwast
    Stéphane Supiot
    Padraig Warde
    Robert G. Bristow
    Nature Reviews Clinical Oncology, 2011, 8 : 107 - 113
  • [45] IMRT pelvic radiotherapy with simultaneous integrated boost in high-risk prostate cancer: Results after 10 years.
    Ekanger, Christian
    Dahl, Olav
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Single institution analysis of pelvic radiotherapy for high risk prostate cancer
    Giurgiu, I.
    Pascale, M.
    Azinwi, C.
    Marongiu, B.
    Pittoni, P.
    Picardi, C.
    Martucci, F.
    Valli, M. C.
    Richetti, A.
    Roggero, E.
    Pesce, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (12) : 1088 - 1088
  • [47] Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
    Wang, Shih-Chang
    Ting, Wei-Chen
    Chang, Yun-Ching
    Yang, Ching-Chieh
    Lin, Li-Ching
    Ho, Hsiu-Wen
    Chu, Shou-Sheng
    Lin, Yu-Wei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
    Hoeh, Benedikt
    Wuernschimmel, Christoph
    Flammia, Rocco S.
    Horlemann, Benedikt
    Sorce, Gabriele
    Chierigo, Francesco
    Tian, Zhe
    Saad, Fred
    Graefen, Markus
    Gallucci, Michele
    Briganti, Alberto
    Terrone, Carlo
    Shariat, Shahrokh F.
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre, I
    PROSTATE, 2022, 82 (01): : 120 - 131
  • [49] POSTOPERATIVE WHOLE ABDOMINO-PELVIC IRRADIATION FOR PATIENTS WITH HIGH-RISK ENDOMETRIAL CANCER
    MARTINEZ, A
    SCHRAY, M
    PODRATZ, K
    STANHOPE, R
    MALKASIAN, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (02): : 371 - 377
  • [50] Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines
    Singh, M.
    Maitre, P.
    Mody, R.
    Murthy, V.
    CLINICAL ONCOLOGY, 2024, 36 (07) : 445 - 451